Where coordination tax is likelyhurting Acme the most.
The cost of holding cross-functional work together when no system owns it end to end. Read cold from public data, every figure labelled by where it came from.
Acme Medical Devices, recognized via Factors.aiNot you?
Estimated coordination tax modelled
$3.2M to $5.1M a year
- Quality and corrective actionassumed8/10
- Regulatory and audit exposureinferred8/10
- Supplier and supply chainassumed7/10
- Change and document controlassumed7/10
Is this Acme Medical Devices?
We pulled this from public sources. Confirm it, or point us at the right company, then tell us where you sit.
What we found public
- Industry
- Medical device manufacturer
- Size
- ~1,200 employees
- Sites
- 3
- Regulation
- FDA & ISO 13485
- On file
- 2 Form 483s
Tailor the read
4 colleagues from Acme have looked at this in the last 30 days. Coordination tax is a team problem; the more you tell us, the sharper this gets.
Already know your numbers? Confirm them in the full report.
Where coordination tends to hurt.
Industry-typical readings for a manufacturer your size, sharpened where a public signal supports it. Every figure is assumed until you confirm it.
The whole-company picture, across every function. Drop into the area you own, or open the leadership view for the business consequences.
Total coordination tax
$3.2M to $5.1M a year, ~18-24% of operating costmodelled
The whole-company figure. The breakdown below shows which functions carry it; the leadership tab reframes it as business consequences.
Quality and corrective action
the heaviest single area, typicalassumed
CAPA closure, audit readiness, and recurrence absorb the most coordination of any function.
Supplier and supply chain
a major share, typicalassumed
Qualification, supplier corrective actions, and continuity chased across the company boundary.
Change and document control
a major share, typicalassumed
Multi-function approvals and record-keeping run in sequence across engineering, quality, and manufacturing.
Operations and the floor
holds and lost capacity, typicalassumed
Production waits on cross-functional decisions; supervisor time goes to chasing and status.
Regulatory and audit exposure
2 Form 483s on fileinferred
Reconstruction-based audit prep keeps inspection risk concentrated and recurring.
Read this honestly. We have not measured Acme’s systems. These are industry-typical assumptions for your size and regulatory profile, a starting hypothesis rather than a verdict. Tell us your actual numbers and each assumed figure is replaced with your own; only then do we benchmark you against peers.
- confirmed
- you told us
- inferred
- derived from a public signal
- assumed
- industry-typical default
- modelled
- computed by our model
Two themes carry half of it.
The modelled mix for your industry, grouped into comparable themes with the domains inside each. Your own mix is confirmed once you share your volumes.
Modelled mix · medical devices modelled
52%
of the modelled tax sits in two themes: Controlled change & records, and Quality events & corrective action.
- Controlled change & records27%
- Change control 15%
- Document & records control 9%
- Periodic review & data governance 3%
- Quality events & corrective action25%
- Nonconformance & CAPA 19%
- Post-market & recall 5%
- Compliance 1%
- Supplier & supply chain19%
- Supplier quality 13%
- Supply chain & planning 4%
- Procurement & sourcing 2%
- Regulatory & customer11%
- Regulatory affairs 8%
- Customer management 3%
- People & operations10%
- Operations 6%
- Training & competency 4%
- Product & systems8%
- New product development 7%
- System & data integration governance 1%
18 to 24 percent of operating cost.
Our model’s range for medical device manufacturers your size. Until we have your numbers, your position inside it is an estimate, not a measurement.
Our estimate for Acme modelled
$3.2M to $5.1M
a year
Wide range because it is built from public data only. Confirming your volumes narrows it.
Confirm your numbersWhere you sit in the band
Share of operating cost spent holding cross-functional work together, medical device manufacturers your size.
One root cause underneath all of it. Your system of record stores what is officially true. The work that produces those records runs in email, meetings, and spreadsheets. The gap between the two is the tax, and it bites hardest around a trigger: an audit, a 483, a recall, a new quality leader, an acquisition.
This range is Unifize’s model for your industry and size, not a published statistic and not a measurement of Acme. The report replaces assumptions with your actuals and states the confidence at every step.
Already being reduced.
“Tasks that have taken weeks or months are now completed in days.”
75%
faster issue closure in the first month
5 → 1
quality systems consolidated into one
In your industryRecovery Force, an FDA-regulated, ISO 13485 wearable device maker, runs CAPA, complaints, audits, and change control on Unifize through a 483 observation.
The full picture, and what to do about it.
This page is the cold read from public data. The full report confirms your numbers, then shows how you compare and how it gets reduced.
- 01
Where you sit across every industry
Medical devices against aerospace, pharma, automotive, and the rest.
- 02
How you compare to your peers
Once your numbers are confirmed, against the median and top quartile.
- 03
Your tax from six angles
By process, economic layer, waste type, team, site, and theme.
- 04
A deep dive into your domain
Quality, supplier quality, change control, or your area, broken into stages.
- 05
How we assessed you
Every signal we used, labelled confirmed, inferred, or assumed.
- 06
How Unifize removes it
The mechanism for each kind of waste, plus a CFO one-pager.
Turn this read into a measured number.
A short conversation replaces the assumptions with your actuals; a two-week Phase 0 measures it for real.